Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Services » Medical Or Nursing Services
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DVA | DaVita HealthCare Partners Inc. | 2.33% | 63.30 | 2.3% | $199.19m | |
| CHE | Chemed Corporation | 0.10% | 419.98 | 10.1% | $46.74m | |
| AMED | Amedisys, Inc. | -1.37% | 130.93 | 11.6% | $28.68m | |
| ACHC | Acadia Healthcare Company, Inc. | 2.57% | 32.79 | 27.2% | $26.95m | |
| LHCG | LHC Group, Inc. | 0.68% | 118.41 | 2.9% | $21.13m | |
| ADUS | Addus HomeCare Corporation | -0.95% | 77.36 | 1.2% | $18.13m | |
| MD | MEDNAX, Inc. | 0.00% | 23.97 | 11.3% | $17.17m | |
| NEO | NeoGenomics, Inc. | 1.26% | 21.63 | 6.1% | $15.05m | |
| USPH | U.S. Physical Therapy, Inc. | 1.89% | 133.14 | 4.8% | $11.38m | |
| ENSG | Ensign Group, Inc. | 2.06% | 49.51 | 5.8% | $10.56m | |
| FMS | Fresenius Medical Care AG & Co. KGaA Sponsored ADR | 0.49% | 34.92 | 0.1% | $5.26m | |
| RDNT | RadNet, Inc. | 0.53% | 15.21 | 0.5% | $3.56m | |
| CO | China Cord Blood Corporation | 0.00% | 4.58 | 0.3% | $0.61m | |
| PDEX | Pro-Dex, Inc. | 0.52% | 15.46 | 0.1% | $0.35m | |
| VNRX | Volitionrx Limited | -2.24% | 3.92 | 0.6% | $0.21m |
Company Profile
NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through two segments: Clinical Services Segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. Pharma Services segment: provides comprehensive testing services in supports pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.